Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P253
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huseni, Mahrukh
Totpal, Klara
Du, Changchun
Dalpozzo, Katie
Zhu, Jing
Rishipathak, Deepali
McNamara, Erin
Jonshtone, Bernadette
Hegde, Priti S
Rhee, Ina
Damico-Beyer, Lisa
Kim, Jeong
Article History
First Online: 6 November 2014